News | April 17, 2009

GE, Brigham and Women’s Hospital Seal Molecular Imaging Research Deal

April 17, 2009 - GE Healthcare announced the company has signed a research agreement with Brigham and Women’s Hospital, an affiliate of Harvard Medical School, to establish an alliance in medical research in area of Positron Emission Tomography (PET).

The collaboration will leverage GE Healthcare’s Molecular Imaging (MI) research efforts to develop personalized approaches to the diagnosis and management of patients with oncologic, neurologic and cardiovascular diseases.

“Collaborations of this caliber are direct investments in the future of healthcare,” said Terri Bresenham, vice president of the GE Healthcare Molecular Imaging business. “Brigham and Women’s world-class patient care, in conjunction with their stellar research and clinical-trial track record, make them an optimal partner in discovering new MI technologies to diagnose and treat disease.”

Brigham and Women’s Hospital has consistently been a leader in the adoption of new medical imaging technologies and establishing their value in the clinic. Clinicians and scientists from both BWH and GE Healthcare plan to use the tools of molecular imaging and radiopharmaceutical development to further the cause of developing personalized approaches to the diagnosis and management of patients with oncologic, neurologic and cardiovascular diseases.

GE Healthcare’s Molecular Imaging division has 2,500 scientists at GE’s Global Research Centers with resources in chemistry, biology, drug development, engineering and imaging technology.

“The more we understand about disease from a clinical standpoint, the better equipped we are to build technologies to improve patient care,” said Jean-Luc Vanderheyden, GE Healthcare’s Global Molecular Imaging Leader. “This collaboration has the ability accelerate the process of developing more effective methods of diagnosing, treating and monitoring disease.”

For more information: www.gehealthcare.com

Related Content

Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging| July 07, 2017
Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are major causes of...
PET imaging, atherosclerotic plaque, inflammation, Ga-68-pentixafor, Technishe Universitat Munchen, Germany

Note the high uptake of Ga-68-pentixafor on multi-planar reconstructions in the organs expressing CXCR4 such as the spleen (red arrows) and adrenal glands (yellow arrows), which was nearly completely blocked by the pre-injection of AMD 3100, a potent CXCR4 inhibitor. Strong accumulation of Ga-68-pentixafor was also found in the kidneys (asterisks) reflecting the renal clearance of the tracer. In addition, high, focal activities were detected in the abdominal aorta (red arrowheads) and right carotid artery (orange arrowheads) of atherosclerotic rabbits, whereas no significant signal could be detected in the non-injured left carotid artery (white arrowheads) of atherosclerotic and control rabbits, as well as in the abdominal aorta and right carotid artery of control rabbits. Furthermore, focal activities detected with PET in atherosclerotic plaques of the abdominal aorta and the right carotid artery decreased significantly when the same rabbit was re-imaged after blocking CXCR4 receptors. Image courtesy of Fabien Hyafil, M.D., Ph.D., Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

News | PET Imaging| March 03, 2017
In the featured article of the March 2017 issue of The Journal of Nuclear Medicine, researchers demonstrate that a new...
ASNC, SNMMI, position statement, myocardial perfusion PET, coronary artery disease
News | PET Imaging| September 01, 2016
September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of...
cardiac PET, myocardial perfusion, PET-CT, cardiac perfusion

A PET-CT cardiac perfusion exam from a Siemens Biograph scanner. The black and white areas of the image show the CT imaging of the anatomy. The colored portion shows the PET overlay on the myocardium and is color-coded to show tracer uptake values. This can show areas of the heart muscle where there are perfusion defects cause by infarcts or coronary artery blockages due to a heart attack and help determine the severity of the ischemia.

Feature | PET Imaging| June 03, 2016 | Dave Fornell
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enabl
blood clot detection, single scan, rats, radionuclides, Peter Caravan, whole body

The whole body of a rat can be imaged for blood clots with one PET scan (which is overlaid here on an MRI image) using the FBP8 probe. Arrow points to a blood clot. Image courtesy of Peter Caravan, Ph.D.

News | PET Imaging| September 23, 2015
September 23, 2015 — New research de
Overlay Init